Page last updated: 2024-08-26

nicotine and solabegron

nicotine has been researched along with solabegron in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cellek, S; Hafsi, N; Kober, OI; Langer, R; Lee, K; Li, Q; Michel, K; Schemann, M; Wollmann, J; Zeller, F	1

Other Studies

1 other study(ies) available for nicotine and solabegron

Article	Year
The beta3-adrenoceptor agonist GW427353 (Solabegron) decreases excitability of human enteric neurons via release of somatostatin. Gastroenterology, 2010, Volume: 138, Issue:1 Topics: Action Potentials; Adipocytes; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Aged; Aniline Compounds; Benzoates; Biphenyl Compounds; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Female; Ganglionic Stimulants; Humans; In Vitro Techniques; Intestines; Male; Middle Aged; Myenteric Plexus; Neurons; Nicotine; Propanolamines; Receptors, Adrenergic, beta-3; Somatostatin; Submucous Plexus	2010

Article

Year

The beta3-adrenoceptor agonist GW427353 (Solabegron) decreases excitability of human enteric neurons via release of somatostatin.

Gastroenterology, 2010, Volume: 138, Issue:1

Topics: Action Potentials; Adipocytes; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Aged; Aniline Compounds; Benzoates; Biphenyl Compounds; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Female; Ganglionic Stimulants; Humans; In Vitro Techniques; Intestines; Male; Middle Aged; Myenteric Plexus; Neurons; Nicotine; Propanolamines; Receptors, Adrenergic, beta-3; Somatostatin; Submucous Plexus

2010